Kinase Enzyme Movement Could Be Key to Novel Cancer Drugs

News   May 16, 2018 | Original story from University of Arizona

 
Kinase Enzyme Movement Could Be Key to Novel Cancer Drugs

The inactive form (left) of the MAPK p38 enzyme moves in an uncoordinated fashion. Once the necessary molecules (blue blob and P symbols) bind, the enzyme becomes active (right) by moving in a coordinated fashion to do its job inside a cell. Credit: Senthil Ganesan, University of Arizona Department of Chemistry and Biochemistry.

 
 
 

RELATED ARTICLES

SpiderMass Device to Speed Up Cancer Surgery

News

A new proteomic assay called SpiderMass which heats water in human tissue to enable ion analysis will allow doctors to speed up cancer surgery by locating tumor biomarkers more quickly.

READ MORE

Diamonds Could Decrease Cost of Imaging and Spectroscopy Devices

News

A new approach shows great promise for enhancing the signal from magnetic resonance imaging (MRI) and nuclear magnetic resonance (NMR) using lasers without expensive magnets.

READ MORE

Antitumor Immune Function in Liver Controlled by Gut Microbiome

News

Scientists have found a connection between bacteria in the gut and antitumor immune responses in the liver. The study showed that bacteria found in the gut of mice affect the liver’s antitumor immune function. The findings have implications for understanding the mechanisms that lead to liver cancer and for therapeutic approaches to treat them.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy